3D Printed Products For The Cannabis Industry
Innovation technology excites with it’s promise for new and better products. 3 Dimensional printing is now being applied to create cannabis tablets that give patients THC, CBD and terpinoids faster and more reliably than smoking marijuana or vaping marijuana oil extract. This patent pending product is being developed for home-based printer application, as well as centralized pharmaceutical manufacturing and distribution within the current USA States that authorize medical and consumer cannabis products.
This breakthrough product application was inspired by FDA approval for Aprecia Pharmaceuticals’ dissolvable epilepsy drug Spritam (levetiracetam) using their 3D printing method, ZipDose, where dosages of up to 1,000 mg can be easily administered.
Applying the technology to cannabis extracts required bringing together experts in diverse fields of engineering, pharmaceutical production, patent protection and cannabis.
While many 3D printer products don’t need regulatory approval, Food and Drug Administration (FDA) has shown it is up to the technology challenge using it’s fast-track medical device approval process called “510k”. The FDA is working with universities, researchers, and industry to continue learning more about these products, so they can better issue guidance on the continuing medical creations. The Agency has now issued further guidance on 3D printing in video format
FDA senior research engineer Lt. James Coburn explains that by regulating medical products, researching important areas for advancing regulatory science, and serving as a resource to foster innovation while still protecting the public health, they can do their due diligence for 3D printing in the medical field.
Our FDA consulting group, Regulatory Affairs Associates www.regaffairs.net is on the cutting edge for regulatory approval for these and other cannabis innovation products.
